Lv5
910 积分 2025-05-29 加入
Anti-BCMA CAR-T for the treatment of IgG4-related disease: clinical assessment and single-cell transcriptomic analysis
11小时前
已完结
Validation of BCMA-CD19 Compound CAR-T Therapy in SLE Overlap Syndrome: Over 1.5-Year Follow-Up
11小时前
已完结
POS0656 TOLERABILITY AND EFFICACY OF BMS-986353 (CC-97540), A CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY MANUFACTURED USING A NEXT-GENERATION PROCESS FOR SYSTEMIC SCLEROSIS: UPDATED DATA FROM THE PHASE 1 BREAKFREE-1 STUDY
12小时前
求助中
Functional study of tilapia T cell activation stimulus signal molecule CD2
4天前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
5天前
已完结
Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation
5天前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
5天前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
5天前
已完结
Precision medicine in systemic lupus erythematosus
6天前
已完结
Purification of Basophils from Peripheral Human Blood
6天前
已完结
皖公网安备34019202002308
